Eduard Serra
About
Eduard Serra is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology.
According to data from OpenAlex, Eduard Serra has authored 77 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Neurology, 25 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Eduard Serra's work include Neurofibromatosis and Schwannoma Cases (49 papers), Sarcoma Diagnosis and Treatment (25 papers) and Neuroblastoma Research and Treatments (16 papers). Eduard Serra is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (49 papers), Sarcoma Diagnosis and Treatment (25 papers) and Neuroblastoma Research and Treatments (16 papers). Eduard Serra collaborates with scholars based in Spain, United States and United Kingdom. Eduard Serra's co-authors include Bernat Gel, Conxi Lázaro, Roger Brent, C. Gustavo Pesce, Andrew H. Gordon, Alejandro Colman‐Lerner, Marcus Buschbeck, Miguel A. Peinado, Roberto Malinverni and Anna Díez-Villanueva and has published in prestigious journals such as Nature, Nature Communications and Nature Genetics.
In The Last Decade
Eduard Serra
73 papers receiving 3.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Eduard Serra Spain | 25 | 1.5k | 1.0k | 594 | 524 | 311 | 77 | 3.0k | ||
| Long‐Sheng Chang United States | 34 | 2.9k 1.9× | 571 0.6× | 1.6k 2.7× | 213 0.4× | 185 0.6× | 82 | 4.6k | ||
| Peter C. Scacheri United States | 41 | 4.8k 3.1× | 399 0.4× | 1.0k 1.7× | 556 1.1× | 103 0.3× | 80 | 6.5k | ||
| G.J.B. van Ommen Netherlands | 37 | 3.3k 2.2× | 274 0.3× | 1.3k 2.2× | 121 0.2× | 85 0.3× | 91 | 4.8k | ||
| Masaru Tamura Japan | 29 | 1.6k 1.1× | 188 0.2× | 516 0.9× | 259 0.5× | 59 0.2× | 121 | 2.9k | ||
| Kathy Boon United States | 25 | 1.8k 1.2× | 262 0.3× | 384 0.6× | 267 0.5× | 41 0.1× | 40 | 2.8k | ||
| Ralph Meuwissen Netherlands | 19 | 2.6k 1.7× | 174 0.2× | 428 0.7× | 424 0.8× | 39 0.1× | 25 | 4.1k | ||
| Mark Berryman United States | 24 | 1.8k 1.2× | 517 0.5× | 181 0.3× | 259 0.5× | 58 0.2× | 34 | 3.0k | ||
| Norman A. Doggett United States | 33 | 2.5k 1.6× | 137 0.1× | 1.1k 1.9× | 103 0.2× | 76 0.2× | 88 | 3.5k | ||
| Kevin Wei United States | 14 | 3.2k 2.1× | 91 0.1× | 232 0.4× | 486 0.9× | 322 1.0× | 23 | 5.6k | ||
| Maria‐Magdalena Georgescu United States | 24 | 1.4k 0.9× | 191 0.2× | 110 0.2× | 156 0.3× | 65 0.2× | 34 | 2.6k |
Countries citing papers authored by Eduard Serra
Since
Specialization
Citations
This map shows the geographic impact of Eduard Serra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduard Serra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduard Serra more than expected).
Fields of papers citing papers by Eduard Serra
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eduard Serra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduard Serra. The network helps show where Eduard Serra may publish in the future.
Co-authorship network of co-authors of Eduard Serra
This figure shows the co-authorship network connecting the top 25 collaborators of Eduard Serra. A scholar is included among the top collaborators of Eduard Serra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduard Serra. Eduard Serra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Jiménez, A., Eduard Serra, & Rodrigo Quian Quiroga. (2025). A new approach to quantify information in real-life, complex neuroscience processes. Comment on “Kinematic coding: Measuring information in naturalistic behavior” by Becchio, Pullar, Scaliti and Panzeri. Physics of Life Reviews. 53. 236–238.
2.
Bai, Ren-Yuan, Jianan Liu, Yuqing Lu, et al.. (2025). Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. Nature Communications. 16(1). 8594–8594.
3.
Carrió, Meritxell, Bernat Gel, Alberto Villanueva, et al.. (2025). New models for MPNST: establishment and comprehensive characterization of two tumor cell lines. Cancer Cell International. 25(1). 268–268.
4.
Fernández‐Rodríguez, Juana, Ignacio Blanco, Claudia Valverde, et al.. (2024). Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models. Clinical Cancer Research. 31(5). 907–920.
5.
Staedtke, Verena, Piotr Topilko, Lu Q. Le, et al.. (2023). Existing and Developing Preclinical Models for Neurofibromatosis Type 1−Related Cutaneous Neurofibromas. Journal of Investigative Dermatology. 143(8). 1378–1387.
6.
Fernández‐Rodríguez, Juana, Yvonne Richaud‐Patín, Ernest Terribas, et al.. (2022). Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas. Cell Reports. 38(7). 110385–110385.
7.
Rodríguez, Anna Duat, Juan Luís Becerra, Sandra Bonache, et al.. (2022). Neurofibromatosis type 1 families with first-degree relatives harbouring distinct NF1 pathogenic variants. Genetic counselling and familial diagnosis: what should be offered?. Journal of Medical Genetics. 59(10). 1017–1023.
8.
Fernández‐Rodríguez, Juana, María Martínez‐Iniesta, Rajarshi Guha, et al.. (2022). A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. Molecular Cancer Therapeutics. 21(7). 1246–1258.
9.
Munera‐Campos, Mónica, et al.. (2022). Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas. Journal of the European Academy of Dermatology and Venereology. 36(9). 1632–1640.
10.
Galván‐Femenía, Iván, Juan Luís Becerra, Isabel Bielsa, et al.. (2021). Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic component. Journal of Medical Genetics. 59(7). 678–686.
11.
Fernández‐Rodríguez, Juana, Ernest Terribas, Cleofé Romagosa, et al.. (2021). Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiation. Human Genetics. 140(8). 1241–1252.
12.
Valle, Jesús Del, Elisabeth Castellanos, Lídia Feliubadaló, et al.. (2021). CNVfilteR: an R/Bioconductor package to identify false positives produced by germline NGS CNV detection tools. Bioinformatics. 37(22). 4227–4229.
13.
Valle, Jesús Del, Lídia Feliubadaló, Marta Pineda, et al.. (2020). Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer. Journal of Medical Genetics. 59(1). 75–78.
14.
Terribas, Ernest, Marco A. Fernández, Juana Fernández‐Rodríguez, et al.. (2020). KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. Neuro-Oncology Advances. 2(Supplement_1). i62–i74.
15.
Valle, Jesús Del, Elisabeth Castellanos, Lídia Feliubadaló, et al.. (2020). Evaluation of CNV detection tools for NGS panel data in genetic diagnostics. European Journal of Human Genetics. 28(12). 1645–1655.
16.
Castellanos, Elisabeth, Bernat Gel, Andreu Alibés, et al.. (2019). Mutational spectrum by phenotype: panel‐based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café‐au‐lait macules. Clinical Genetics. 97(2). 264–275.
17.
Gel, Bernat & Eduard Serra. (2017). karyoploteR: an R/Bioconductor package to plot customizable genomes displaying arbitrary data. Bioinformatics. 33(19). 3088–3090.
18.
Patel, Ami V., David Eaves, Walter J. Jessen, et al.. (2012). Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target. Clinical Cancer Research. 18(18). 5020–5030.
19.
Serra, Eduard, Elisabet Ars, Anna Ravella, et al.. (2001). Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations. Human Genetics. 108(5). 416–429.
20.
Ars, Elisabet, H. Kruyer, Antonia Gaona, et al.. (1998). A Clinical Variant of Neurofibromatosis Type 1: Familial Spinal Neurofibromatosis with a Frameshift Mutation in the NF1 Gene. The American Journal of Human Genetics. 62(4). 834–841.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Long‐Sheng Chang Breakdown of academic impact, for papers by Peter C. Scacheri Breakdown of academic impact, for papers by G.J.B. van Ommen Breakdown of academic impact, for papers by Masaru Tamura Breakdown of academic impact, for papers by Kathy Boon Breakdown of academic impact, for papers by Ralph Meuwissen Breakdown of academic impact, for papers by Mark Berryman Breakdown of academic impact, for papers by Norman A. Doggett Breakdown of academic impact, for papers by Kevin Wei Breakdown of academic impact, for papers by Maria‐Magdalena Georgescu